Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

The report can be accessed by licensed users only by using the 'Programs' icon in on top of the dashboardscreen. The dashboard programs icon will be active for users participating in any particular program and greyed out for all others.


Image RemovedImage Added


A click on the programs icon will open the programs window which will show all programs the user is licensed for, in the example below the Amgen REFRAME program.

...

  • Patients that have experienced a fracture since the age of 50


Image RemovedImage Added


In addition to the report tab, a new filter tab will be available when the REFRAME program is selected. This new filter tab is under the Programs heading and is called 'REFRAME Osteoporosis'. It allows you to filter for patients with lapsed osteoporosis medication (>12mths <5yrs) in addition to the report criteria described above.


Image RemovedImage Added


The following columns will be displayed within the report and populated if the data is stored within the patients recorded in a coded format. Columns listed below are in order and displayed from left to right within the report.


Item

Column Name

Display value or format

1

Surname

Patients full surname

2

First name

Patient full first name

3

Sex

F or M

4AgeAge in Years

5

>=70yrs and no DXA or >2yrs since last DXA

Y or blank (nothing displayed)

6

Experienced a fracture since age of 50

Y or blank (nothing displayed)

7

Osteoporosis

Y or blank (nothing displayed)

8

Minimum Trauma Fracture

Y or blank (nothing displayed)

9

Received bone active medication in the last 5yrs

Y or blank (nothing displayed)

10

Glucocorticoid drug class >7.5mg per day for >3 months

Y or blank (nothing displayed)

11

BMI <20

Y or blank (nothing displayed)

12

hyperthyroidism

Y or blank (nothing displayed)

13

Smoking

Smoking status from the clinical system or blank

14

Coeliac Disease

Y or blank (nothing displayed)

15

Primary Hyperparathyroidism

Y or blank (nothing displayed)

16

Previous treatment with aromatase inhibitor drug class

Y or blank (nothing displayed)

17

History of poor calcium intake

Y or blank (nothing displayed)

18

History of low vitamin D

Y or blank (nothing displayed)

19

Inflammatory conditions associated with bone loss

Y or blank (nothing displayed)

20

CKD

Please see below for details on this indicator

21

Diagnosis Sarcopenia

Y or blank (nothing displayed)

22>=70yrs and no DXA or >5yrs since last DXAY or blank (nothing displayed)
23Lapsed Osteoporosis medication >12mths and <5yrsY or blank (nothing displayed)


CKD displays stages of CKD (indicated or diagnosed) as well as likelihood of the indication based on the extracted pathology
results.

  • Indicated Staging of CKD
  • Color code for the Clinical Action Plan to manage CKD

Patients on dialysis are displayed as 'level 5' CKD.

For this report CAT will ignore any diagnosis of Kidney disease and the displayed indicated stages are purely based on the
eGFR and ACR results in the patient record.

Colour codes and their meaning:

Red
•Clinical Action Plan to be monitored 1-3 monthly

Orange
•Clinical Action Plan to be monitored 3-6 monthly

Yellow
•Clinical Action Plan to be monitored 12 monthly

For more information refer to Kidney Health Australia web site and the CKD Guideline Booklet available at www.kidney.org.au
Detection of CKD requires follow up testing once an abnormal result is recorded. The outcome of 3 tests over a 3 month
period will inform a diagnosis. CAT4 is only using the most recent eGFR and ACR, not the last 3 results. This will

•inform a diagnosis if 3 tests have been done or
•flag that a patient should be recalled for follow up testing if there are not 3 results in the Patient Record.

For full details on the CKD stage calculation please see here: http://kidney.org.au/cms_uploads/docs/02_algorithm-for-inital-detection-of-ckd.pdf


The following functionality found also within the Cleansing CAT reports will be made available and functional within the REFRAME – Osteoporosis report:

...